Beacon Therapeutics is a startup based in the United States, most recent round Series-c-plus, 3 tracked investors.
Beacon Therapeutics is a startup based in the United States. Its most recent tracked round is Series-c-plus. Brouky records 3 investors associated with the company.
Beacon Therapeutics is an ophthalmic gene therapy company developing AAV-based treatments to restore and improve vision for patients with inherited and other retinal diseases. Its lead asset, AGTC-501 (laru-zova), is in Phase III clinical trials for X-linked retinitis pigmentosa (XLRP).
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.